Pharmaceutical Technology

NOVEMBER 25, 2022

In many cases, pharma companies select a contract development and manufacturing organisation (CDMO) to develop products versus doing the work themselves for reasons related to cost, convenience, and capacity. The differences between adult and paediatric dosage forms are typically significant. Faster to market.

Manufacturing 130

Manufacturing Production Pharma Companies Development 130

pharmaphorum

NOVEMBER 1, 2021

It was discovered by scientists led by Prof Tomoki Todo of the University of Tokyo. There also seems to be an appetite among big pharma companies for oncolytic virus assets, with Johnson & Johnson, Boehringer Ingelheim, AstraZeneca, Kissei Pharma and Merck & Co making recent deals in this area.

Genetic Engineering 122

Genetic Engineering Clinical Trials Clinical Trials Trials 122

Pharmaceutical Technology

SEPTEMBER 7, 2022

The information contained in the download document is intended for benefit managers, executives, manufacturers, distributors, suppliers, health insurers, product development scientists, and other individuals involved in the pharmaceutical industry.

Pharmacy 100

Pharmacy Containment Manufacturing Compliance 100

pharmaphorum

DECEMBER 15, 2021

Dialogue requires humility on the drug company’s side—accepting that sometimes we are wrong about matters we think we understand—and trust on the patients’ side that representatives of large, for-profit entities really have come to listen.

Pharma Companies 145

Pharma Companies Development Medicine Drugs 145

Pharmaceutical Technology

DECEMBER 5, 2022

Out of the total job titles, the top five roles commanded a 96.05% share in the overall IT recruitment activity of the UK’s pharma industry in November 2022. 3) Computer and Information Research Scientists held a share of 7.89%, registering a 14.29% decline from October 2022.

Pharma Companies 100

Pharma Companies Scientist Development Research 100

Pharmaceutical Technology

SEPTEMBER 8, 2022

The information contained within the download document is designed for pharmaceutical executives, developers, research scientists and associates, regulatory solutions consultants, and any other individual involved in API biologics production in the pharmaceutical industry.

Gene 100

Gene Marketing Vaccination Vaccine 100

Pharmaceutical Technology

SEPTEMBER 8, 2022

The list of pharmaceutical solid dose manufacturing companies includes providers of solid state and pre-formulation technologies, IND/NDA filing support, technologies for cGMP manufacturing of APIs and intermediates from lab to commercial scale, process optimisation, and designing and developing manufacturing processes.

Manufacturing 100

Manufacturing Marketing Contract Manufacturing Containment 100

pharmaphorum

NOVEMBER 23, 2021

It can accommodate more than 2,200 research scientists, has 19,000 square metres of lab space, and boasts “the most advanced robotics, high-throughput screening and AI-driven technology,” according to AZ.

Gene Editing 105

Gene Editing Life Science Pharma Companies Clinical Trials 105

pharmaphorum

SEPTEMBER 16, 2021

The decision by shareholders has been greeted with consternation by health charities, public health specialists and doctors organisations, which have mounted a campaign against placing a pharma company in the hands of a big tobacco group. — Sarah Woolnough (@swoolnough) September 16, 2021.

Scientist 90

Scientist Production Marketing Pharma Companies 90

pharmaphorum

SEPTEMBER 29, 2020

Cell therapy research has been built on collaborations amongst scientists and entrepreneurs, providing early proof of concept for modalities thought to be too difficult to commercialise but with a strong potential for patient benefit”. Case Study: From Technology Agreement to co-development and co-commercialisation partnership.

Research 132

Research Gene Editing Development Gene 132

XTalks

OCTOBER 1, 2020

Leaving academia for industry is a route that academic scientists and professors did not traditionally pursue in the past due to perceived differences in skillsets, experiences and even associated stigmas. WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation.

Scientist 52

Scientist In-Vitro Research Life Science 52

pharmaphorum

JUNE 14, 2021

Delytact is an engineered herpes simplex virus type 1 (HSV-1) designed to selectively replicate in – and kill – tumour cells without affecting normal tissues, and was discovered by scientists led by Prof Tomoki Todo of the University of Tokyo.

Clinical Trials 119

Clinical Trials Clinical Trials Trials Pharma Companies 119

pharmaphorum

MARCH 16, 2021

Antiverse – which was co-founded in 2017 by engineers Murat Tunaboylu and Ben Holland – says it will use the cash injection to build a new laboratory in Cardiff and expand its technical team through recruitment of specialist machine learning engineers, laboratory scientists and structural biologists.

Antibody 101

Antibody Bioavailability Engineer Drugs 101

pharmaphorum

AUGUST 12, 2022

It’s been developed in collaboration with pharma companies to offer a way to incorporate EEG testing in clinical trials much more easily than at present, with the opportunity to harvest much more data over time.

Trials 105

Trials Clinical Trials Clinical Trials FDA Approval 105

Pharmaceutical Technology

SEPTEMBER 23, 2022

While it’s tempting to choose a large CDMO that manufactures a wide range of products, it’s often better to find a company that focuses on a narrower band of core strengths. Avéma’s team of scientists and manufacturing experts have more than 40 years of Rx formulation development expertise and decades of producing.

Manufacturing 147

Manufacturing Drugs Production Development 147

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations?

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Reagent Pharma Companies Scientist 52

pharmaphorum

JANUARY 24, 2022

The UK scientists that ran one of the largest trials of experimental COVID-19 drugs have formed a non-profit company that will apply the methodology to other disease areas – with $6.8 million in funding from French drugmaker Sanofi.

Trials 97

Trials Drugs Clinical Trials Clinical Trials 97

pharmaphorum

DECEMBER 1, 2022

Etienne De Braekeleer, Senior Research Scientist, AstraZeneca. Delve into advanced case studies looking into organ models: from the blood-brain barrier to liver spheroids. Featured Speakers Include: Stefan Przyborski, Professor Cell Technology, Durham University. Dr Manjunath Hegde, Scientific Investigator & Associate Fellow, GSK.

In-Vitro 52

In-Vitro Scientist Engineer Gene Therapy 52

pharmaphorum

DECEMBER 15, 2020

Aside from the 17% who said their impression of pharma companies had improved during the pandemic, 54% said their impression had stayed the same and 16% said their impression had got worse. When asked to give an opinion on a range of organisations and roles, just 38% of those interviewed had a favourable opinion of pharma companies.

Pharma Companies 59

Pharma Companies Scientist Development 59

pharmaphorum

APRIL 1, 2021

There are a lot of scientists who want to better understand biology but don’t have the money to do it in wet settings. The tandem of AI and translational scientists can then find the strongest signals and figure out why those targets worked. “You So what do they do? They go into bioinformatics”. So, what do they do?

Bioinformatics 123

Bioinformatics Drugs Development Scientist 123

pharmaphorum

OCTOBER 11, 2022

Tunnah began his career as a scientist, studying biochemistry right through to PhD at the University of Oxford, his work at that time concerning very early stage, novel anti-cancer therapies (or ‘structural biophysics’). This] enabled people to access that in a way they hadn’t done before. The frontiers of patient centricity.

Medicine 98

Medicine Pharma Companies Doctors Doctor 98

pharmaphorum

JULY 5, 2021

The call “is addressed to scientists affiliated to start-ups, biotechs, universities, research centres, and pharmaceutical companies all over the world,” according to the drugmaker.

Dermatology 59

Dermatology Pharma Companies Research Scientist 59

pharmaphorum

JANUARY 24, 2023

The future of R&D The Our Future Health project was funded from various bodies, but the pharma industry was willing to include £100 million of investment, in return for access and insights from the information gathered. Scientists are able to study the aggregated, de-identified genetics of these individuals.

Genetics 98

Genetics Drugs Genome Project Biobanking 98

The Pharma Data

JANUARY 4, 2021

In his brief announcement on social media, Rothenberg said his successor will be Aida Habtezion, a physician-scientist and Associate Dean for Academic Affairs at Stanford University. Aida is an extremely accomplished physician-scientist as well as an inspirational leader.

HR 52

HR Clinical Development Scientist Development 52

pharmaphorum

JANUARY 18, 2022

Biotech / Pharma Companies – Team Leader, Junior Principle investigator, Cell and Molecular Scientist, Chief Scientific Officer, Deputy Director, Manager, Founder, CEO, Head, Director, Programme Manager, Lab Head, Toxicologist. Workshop B: Bioprinting for 3D Cell Culture. Who Should Attend?

In-Vitro 52

In-Vitro Engineer Drugs Pharma Companies 52

pharmaphorum

FEBRUARY 28, 2022

It’s still an emerging area of research, with intriguing findings from scientists working in this area, for example that autoantibody activation is more common in women after asymptomatic infection and in men after a symptomatic infection, which paint a picture of a complex syndrome. million ($1.9

Life Science 52

Life Science Pharma Companies Development Protein 52

pharmaphorum

JUNE 10, 2022

To compete now, companies need to own a larger portion of the treatment journey and the overall patient care experience. Commercial leaders should leverage the internal capabilities and centres of excellence that pharma companies are increasingly building. Partner to deliver at speed.

Marketing 133

Marketing Engineer Bioinformatics Regulation 133

pharmaphorum

JANUARY 24, 2023

David Harel, CEO and co-founder of CytoReason, said: “It’s exciting to see the growing adoption of our technology by world-leading pharma companies. By harnessing our game-changing AI capabilities, we hope to help Sanofi’s scientists identify novel and personalised targets in IBD, and to prioritise targets in their pipeline.”

Medicine 52

Medicine Drugs Pharma Companies Clinical Trials 52

pharmaphorum

FEBRUARY 11, 2022

This technology can be particularly beneficial for rare disease organisations as they often don’t have data scientists at their disposal or full-stack engineers. During the pandemic, numerous digital health companies flourished due to the necessity for virtual solutions, including Komodo Health.

Life Science 105

Life Science Engineer Development Big Data 105

pharmaphorum

FEBRUARY 16, 2021

They had to be nurtured and cared for, despite the fact we, as pharma companies, have very limited direct access to patients. ” What is different is that today we share cloud-based infrastructure and tools with non-pharma companies, like FMCG. This future starts now. About the authors.

Marketing 106

Marketing Production Big Data Pharma Companies 106

Pharmaceutical Technology

DECEMBER 6, 2022

Using MEDELPHARM’s unique compaction simulation machines, scientists can produce prototypes of tablets at the same compression speeds of their industrial rotary press. Most importantly, the machines themselves are highly user friendly – something which has been appreciated by pharma companies and university laboratories around the world.

Containment 130

Containment Development Drugs Contract Manufacturing 130

pharmaphorum

JUNE 8, 2021

Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market. In 2001, he joined as a principal scientist in the oncology team in the drug discovery division and associate director at Johnson & Johnson.

Marketing 105

Marketing Drugs Development Regulation 105

The Pharma Data

DECEMBER 11, 2020

Mark Stevenson, Executive Vice-President and COO at Thermo Fisher Scientific, said: “Combining the academic research capabilities of world recognized scientists at the University of Oxford with Thermo Fisher’s Dartford UK development and manufacturing facility has expanded our serology portfolio for improved Covid-19 epidemiological studies.”.

Antibody 52

Antibody Vaccination Vaccine Containment 52

pharmaphorum

JULY 8, 2022

Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. Novel digital endpoints. About the author. The post Digital tools driving innovative clinical trials appeared first on.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Regulation 100

pharmaphorum

APRIL 19, 2022

RudaCure is a four-year-old biotech company based in the South Korea, focusing on ocular disease and chronic pain with a pair of potentially first-in-class drugs. The company recently raised $16.5 The JP Morgan meeting has already generated some interest from global pharma companies, Kim said.

Marketing 52

Marketing Clinical Trials Clinical Trials Development 52

The Pharma Data

NOVEMBER 10, 2020

Tessier added that control over preclinical studies can lead to a higher likelihood of reproducibility in the clinical setting, as enabling scientists to conduct their own studies can significantly contribute to the production of robust and validated data sets. They can make subtle changes based on what they’re seeing in the data.

Marketing 52

Marketing In-Vivo Scientist Research 52